Fulgent Genetics, Inc.
USD20.36
-0.17 (-0.83%)
CEO
Ming Hsieh
IPO Date
2016-09-29
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$20.52
Prev. Close
$20.53
Day Low
$20.18
Day High
$20.66
52W Low
$13.46
52W High
$31.04
Market Cap
$0.58B
Volume
0.06M
| -13.1 |
| 31 Dec 2023 | FY | 36.1% | -58.0% | -14.8% | -13.6% | 0.01 | 6.96 | -5.1 |
| 31 Dec 2022 | FY | 59.3% | 23.2% | 11.3% | 10.3% | 0.03 | 7.13 | 6.3 |
| 31 Dec 2021 | FY | 78.3% | 51.1% | 43.8% | 39.7% | 0.02 | 5.81 | 5.8 |
| 31 Dec 2020 | FY | 78.7% | 50.8% | 37.6% | 30.6% | 0.03 | 4.02 | 5.5 |
| 31 Dec 2019 | FY | 56.6% | -1.3% | -0.5% | -0.5% | 0.03 | 9.96 | -587.2 |
| 31 Dec 2018 | FY | 49.9% | -26.3% | -10.7% | -10.2% | 0.00 | 15.80 | -10.2 |
| 31 Dec 2017 | FY | 54.3% | -13.4% | -4.6% | -4.4% | 0.00 | 15.51 | -31.0 |
| 31 Dec 2016 | FY | 63.2% | -29.3% | -9.8% | -9.2% | 0.00 | 14.27 | -38.2 |
| -8.6 |
| 30 Sept 2025 | Q3 | 42.2% | -7.9% | -0.6% | -0.5% | 0.01 | 7.01 | -26.3 |
| 30 Jun 2025 | Q2 | 42.1% | -23.2% | -1.7% | -1.6% | 0.01 | 6.01 | -8.1 |
| 31 Mar 2025 | Q1 | 38.6% | -15.7% | -1.0% | -1.0% | 0.01 | 6.32 | -11.3 |
| 31 Dec 2024 | Q4 | 41.8% | -7.7% | -0.5% | -0.5% | 0.01 | 4.85 | -24.0 |
| 30 Sept 2024 | Q3 | 37.3% | -20.4% | -1.3% | -1.2% | 0.01 | 4.41 | -11.3 |
| 30 Jun 2024 | Q2 | 37.3% | -12.3% | -0.8% | -0.7% | 0.01 | 5.27 | -17.3 |
| 31 Mar 2024 | Q1 | 34.3% | -20.9% | -1.2% | -1.1% | 0.01 | 5.09 | -12.1 |
| 31 Dec 2023 | Q4 | 35.8% | -181.8% | -11.3% | -10.4% | 0.01 | 6.96 | -1.7 |